Notes

A fund manager for the Catalyst research fund made some notes. The fund size is 0 and it is for research only. The notes were made on 2026-09-21 at 03:31:39 UTC. The manager looked at some SEC filings, including ones from HITI on 2026-09-14 and BFRI on 2026-09-14. They also looked at some news, including a report from Dave & Buster's on September 14, 2026. The manager reviewed some data, including a review of TSM on September 10 and a review of CAN on September 8. They also looked at some information about EGTX, including a review on September 11 and a conference on September 16. The manager also checked on some trade information, including a notice from the US International Trade Commission about BFRI. The notice said that a suspension was lifted on September 1. The manager made these notes in 11 panels, each with a unique code, or sha, to identify it.

The Catalyst fund is currently in research mode only for the stocks IONS, MIRM, GIS, and EAT, as well as CAG, with a size of 0. As of September 21, 2026, at 02:46:06 UTC, the fund has noted the following: IONS filed a SEC report on September 4, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/874015/000114036126035802/ef20081690_8k.htm. MIRM filed a SEC report on September 8, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/1759425/000175942526000047/mirm-20260902.htm. GIS filed a SEC report on July 1, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/40704/000162828026046337/gis-20260701.htm. EAT filed a SEC report on September 17, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/703351/000070335126000032/eat-20260917.htm. A news scan found the headline that Barclays maintains an overweight rating on Ionis Pharmaceuticals and lowers its price target to $85 on September 9, 2026. GIS had a conference on September 8, 2026, at 19:00 UTC, which has already passed. The fund will review the replay. On September 23, 2026, GIS will release its earnings, and the fund will review the Q&A session at 13:00 UTC. The fund notes that if GIS has stronger organic cash flow, it will record and validate the results, but if the cash flow is weaker or absent, it will reverify the cash flow. The fund does not make automatic entries and only reviews the dates, not the first news. The baseline for GIS is a FY27 EPS of $3.00-3.20, with organic growth of -1.5% to +0.5% and savings of $750 million. The fund also notes that EAT had an investor day on September 17, 2026, and will have an earnings call on October 28, 2026. The fund will review the earnings call at 16:30 UTC and reverify the first news. The fund has a frozen holdout of -19.2065% for EAT and does not make automatic trades. The investor day odds are untested. The fund will verify the full pipelines and early news for all stocks.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 21, 2026, at 02:01:03 UTC. The fund reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. It also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the fund looked at RSS feeds from SAIL on September 9, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The fund also checked the FDA website for information on GRAL, which had a panel meeting scheduled for September 23, 2026. The fund will review new morning results on September 9 at 12:30, LOVE results on September 10 at 12:30, and SFIX results on September 24 at 12:30. The GRAL panel meeting on September 23 is not for approval. The fund has a strong cash position, which will be recorded and validated, while weak or early positions will be cashed out and reverified. No automatic orders were made.

The fund is called Catalyst Research and it is for research only. The size of the fund is 0 and the time is 2026-09-20T23:46:04.165414+00:00. There are several news updates: TLX on Sunday, September 20, 2026, announced a partnership on https://telixpharma.com/news-views/telix-and-itm-join-forces-to-create-a-radiopharmaceutical-powerhouse/. AVO announced its fiscal 2026 third quarter financial results on Tuesday, September 8, 2026, on https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial. ABM reported its fiscal third quarter 2026 results on Tuesday, September 8, 2026, on https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results. ROIV announced positive results from a study on Tuesday, September 8, 2026, on https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. There are also several financial reports: UNFI's 10-K report on September 14, 2026, DRI's 10-K report on July 24, 2026, PPIH's 10-Q report on September 9, 2026, MRK's 10-Q report on August 7, 2026, and WLTH's 10-Q report on September 14, 2026. EPM reported its fiscal fourth quarter and full year results on Tuesday, September 15, 2026, on https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-reports-fiscal-fourth-quarter-and-full-0. IPHA filed a 6-K report on September 17, 2026. The HTTP status codes for KGF, ASKUL, IPHAnews, and SOBI are all 200, with hashes 9ef4336aeb9528cc, e6f0d85c03a37ce6, ef3293fd5ff26cb3, and 7569409d160b2a08, respectively. The research is strong and new, so it is recommended to read the originals and validate the information. For weak or absent information, it is recommended to cash out and reverify. IPHA has a condition on September 17 and Sobi has a receipt conditional on Q1 2028. The monitors 165, 168, 167, 137, and 22 should be preserved. The sources and dates are in the job script and journal. There are no orders.

The fund, called Catalyst, is researching the stocks IONS, MIRM, GIS, and EAT, as well as CAG, with a size of 0. The research was done on September 20, 2026, at 22:31:05 UTC. The fund manager looked at the following SEC filings: IONS on September 4, 2026, MIRM on September 8, 2026, GIS on July 1, 2026, and EAT on September 17, 2026. A discovery was made on September 9, 2026, at 13:12:14Z, when Barclays maintained an overweight rating on Ionis Pharmaceuticals and lowered its price target to $85. GIS had a conference on September 8, 2026, at 19:00 UTC, which has already passed. The fund manager will review the replay. On September 23, 2026, at 13:00 UTC, GIS will have a Q&A session for its earnings release. The fund manager will check the replay because the exact time of the first release is unknown. If GIS has stronger organic cash and guidance, the fund manager will record and validate the results. If the results are weaker or absent, the fund manager will reverify the cash. There will be no automatic entry into the trade. The baseline for GIS is an EPS of $3.00-3.20 for FY27, with organic growth of -1.5% to +0.5% and savings of $750m. The fund manager also looked at EAT, which had an investor day on August 31, 2026, and will have an earnings call on October 28, 2026. The fund manager will review the results on October 28, 2026, at 16:30 UTC and reverify the first news release. If EAT has stronger organic cash, the fund manager will record and independently validate the results. If the results are weaker or absent, the fund manager will reverify the cash. The fund manager will not make any automatic trades. The research is for informational purposes only and no orders will be placed.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 20, 2026, at 21:46:05 UTC. The fund reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. It also reviewed the 8-K filing for SFIX on July 28, 2026. Additionally, the fund looked at RSS feeds from SAIL on September 9, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The fund also checked the FDA website for information on GRAL, which had a panel meeting scheduled for September 23, 2026, but this was not an approval meeting. The fund will review morning results on September 9, LOVE results on September 10, and SFIX results on September 24. The fund has a strong cash position, which will be recorded and validated, while weak or early positions will be cashed out and reverified. No automatic orders were placed.

The fund is called Catalyst Research and its size is 0. It is a compact receipt with origins in the PRE91108 archive. The current date and time is 2026-09-20T19:31:08.108481+00:00. A news scan found the following headlines and data lines: a panel with 70 characters and a sha of c6ce1f855492c303, a panel with 101 characters and a sha of 10ef27123f04ad24 about HITI SEC on 2026-09-14, a panel with 98 characters and a sha of a0b1c61a5d55ddaa about BFRI SEC on 2026-09-14, a panel with 216 characters and a sha of d8aa654ed382a608 about Dave & Buster's second quarter 2026 report, a panel with 246 characters and a sha of c6b13eb6046204c9 about chosen UTC reviews, a panel with 260 characters and a sha of 1a27b01a67d941ba about CAN and PLAY, a panel with 353 characters and a sha of 6c9b3b8c9ef9591b about improved organic cash, a panel with 160 characters and a sha of cb0697f278f531de about EGTX, a panel with 206 characters and a sha of 07d3a925356adce6 about EGTX conferences, a panel with 99 characters and a sha of 11a2f98c1e6f9001 about BFRI ITC, and a panel with 341 characters and a sha of 54d249f97f35ce8c about BFRI ITC lifted suspension. The job has 11 panels and a raw sha of fbf76106f756ac6af5cecb18b8f428cd5de2b694f473e6ed59b9644886769502.

The Catalyst Research fund has a size of 0 as of 2026-09-20T19:31:05.152706+00:00. Recent news includes: TLX on Thu, 17 Sep 2026, with a link to https://telixpharma.com/news-views/lets-go-lets-get-them/, AVO on Tue, 08 Sep 2026, with a link to https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial, ABM on Tue, 08 Sep 2026, with a link to https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results, and ROIV on Tue, 08 Sep 2026, with a link to https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. Financial reports include UNFI's 10-K on 2026-09-14, DRI's 10-K on 2026-07-24, PPIH's 10-Q on 2026-09-09, MRK's 10-Q on 2026-08-07, and WLTH's 10-Q on 2026-09-14. Other updates include EPM on Tue, 15 Sep 2026, with a link to https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-reports-fiscal-fourth-quarter-and-full-0, and IPHA's 6-K on 2026-09-17. HTTP requests returned the following hashes: KGF with hash 9ef4336aeb9528cc, ASKUL with hash e6f0d85c03a37ce6, IPHAnews with hash ef3293fd5ff26cb3, and SOBI with hash 7569409d160b2a08. The research is for informational purposes only, with a note to read originals and validate strong or new information, and to cash and reverify weak, absent, or error information. IPHA has a note from Sep 17, and Sobi has a receipt and Q1-2028 conditional. Monitors 165, 168, 167, 137, and 22 are preserved. There are no orders, and sources and dates are available in the job script and journal.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 20, 2026, at 18:16:05 UTC. The fund is tracking several companies, including IONS, MIRM, GIS, and EAT, as well as CAG. The Securities and Exchange Commission (SEC) filings for these companies are available at the following links: IONS on September 4, 2026, MIRM on September 8, 2026, GIS on July 1, 2026, and EAT on September 17, 2026. On September 9, 2026, Barclays maintained an overweight rating on Ionis Pharmaceuticals, but lowered its price target to $85. GIS had a conference and review on September 8, 2026, at 19:40 UTC, which has already passed. The company will release its earnings on September 23, 2026, at 13:00 UTC, with a question and answer session. The fund will review the earnings, but the exact time of the first release is unknown. If GIS has stronger organic cash flow and guidance, it will be recorded and validated, but if it is weaker or absent, the fund will reverify the cash flow. There will be no automatic entry into the market. The baseline for GIS is an EPS of $3.00-3.20 for FY27, with organic growth of -1.5% to +0.5% and savings of $750 million. The fund also tracks EAT, which had an investor day on September 17, 2026, and will have an earnings call on October 28, 2026. If EAT has stronger organic cash flow, it will be recorded and validated, but if it is weaker or absent, the fund will reverify the cash flow. The fund will review the earnings, but the exact time of the first release is unknown. The fund has a frozen paper window from September 16 to September 21, with a calendar out of sample (OOS) of +0.567% and a stress test of -2.405%. The fund will not retune past tests. The fund is currently in research mode only, with no orders, as of September 20, 2026, at 18:16:08 UTC.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 20, 2026, at 17:31:04 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager looked at RSS feeds from SAIL on September 9, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The manager also checked the FDA website for information on GRAL, which had a panel meeting scheduled for September 23, 2026. The manager noted that the SEC filings may lag behind news and that reviews would be done at specific times, including September 9 at 12:30 for new morning results, September 10 at 12:30 for LOVE, and September 24 at 12:30 for SFIX after the September 23 AMC. The manager also noted that the GRAL panel meeting on September 23 was not for approval. The manager decided to preserve cash, with a record and validation process for strong cash positions and a cash and re-verification process for weak, early, or absent positions. No automatic orders were made.

The Catalyst research fund has a size of 0 as of 2026-09-20T15:16:05.392381+00:00 UTC. Recent news includes: TLX on Thu, 17 Sep 2026, with a link to https://telixpharma.com/news-views/lets-go-lets-get-them/, AVO on Tue, 08 Sep 2026, with a link to https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial, ABM on Tue, 08 Sep 2026, with a link to https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results, and ROIV on Tue, 08 Sep 2026, with a link to https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. Financial reports include UNFI's 10-K on 2026-09-14, DRI's 10-K on 2026-07-24, PPIH's 10-Q on 2026-09-09, MRK's 10-Q on 2026-08-07, and WLTH's 10-Q on 2026-09-14. Other updates include EPM on Tue, 15 Sep 2026, with a link to https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-reports-fiscal-fourth-quarter-and-full-0, and IPHA's 6-K on 2026-09-17. HTTP requests returned the following hashes: KGF with hash 9ef4336aeb9528cc, ASKUL with hash e6f0d85c03a37ce6, IPHAnews with hash ef3293fd5ff26cb3, and SOBI with hash 7569409d160b2a08. The research is for informational purposes only, with a note to read originals and validate strong or new information, and to cash and reverify weak, absent, or error-prone information. A specific note is made about IPHA on Sep 17 and Sobi receipt conditional on Q1-2028. Certain monitors, including 165, 168, 167, and 137, and 22, are to be preserved. The sources and dates are available in the job script and journal, and no orders have been placed.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 20, 2026, at 14:16:04 UTC. The fund is tracking the following stocks: IONS, MIRM, GIS, EAT, and CAG. The fund manager has preserved 126 positions with an exit value of 0. The Securities and Exchange Commission filings for IONS, MIRM, GIS, and EAT are available at the provided links. A news scan found the headline that Barclays maintains an overweight rating on Ionis Pharmaceuticals and lowers its price target to $85. GIS had a conference on September 8, which is already past, but a replay is available. The fund is waiting for General Mills' earnings release on September 23. The baseline expectations for GIS are an EPS of $3.00-3.20, organic growth of -1.5% to +0.5%, and savings of $750 million. The fund has a frozen paper window from September 16 to 21 and is out of sample by 0.567%. EAT had an investor day on September 17 and is scheduled to have an earnings call on October 28. The fund will review the earnings call at 16:30 UTC and reverify the first news release. The fund has a holdout of -19.2065% and will not make automatic trades. The fund manager will verify the full pipelines and early news for the tracked stocks.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 20, 2026, at 13:31:05 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager looked at RSS feeds from SAIL on September 9, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The FDA calendar was also checked for GRAL, which has a panel meeting on September 23, 2026, but this is not an approval meeting. The fund manager will review new morning results on September 9 at 12:30, LOVE results on September 10 at 12:30, and SFIX results on September 24 at 12:30, after the September 23 AMC. The manager will preserve cash and validate records, and will reverify weak or early results. No automatic orders were placed.

A fund manager's notes were found in a data scan. The fund is called Catalyst Research and it has a size of 0. The notes mention compact receipts and origins in the PRE91108 archive, with a timestamp of 2026-09-20T11:16:08.115325+00:00. The notes include a list of panels with previews of various news and updates, including SEC filings for HITI and BFRI on 2026-09-14, a report from Dave & Buster's on September 14, 2026, and updates on TSM, CAN, and EGTX. The notes also mention a lifted suspension by the ITC on September 1, 2026, and a photodynamic therapy systems components investigation. The panels are numbered from 0 to 10 and include links to various websites, including the SEC and USITC. The notes end with a statement that the originals should be read before taking action.

The Catalyst research fund has a size of 0 as of September 20, 2026, at 11:16:04 UTC. The fund manager reviewed the following news: Telix Pharma on September 17, 2026, at https://telixpharma.com/news-views/lets-go-lets-get-them/, Mission Produce on September 8, 2026, at https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial, ABM on September 8, 2026, at https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results, and Roivant on September 8, 2026, at https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. The manager also reviewed financial reports from UNFI on September 14, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, and WLTH on September 14, 2026. Additionally, the manager checked news from Evolution Petroleum on September 15, 2026, and IPHA on September 17, 2026. The manager verified the integrity of data from KGF, ASKUL, IPHAnews, and SOBI. The manager decided to preserve monitors 165, 168, 167, 137, and 22, and to take no orders. The manager noted that IPHA has a condition related to Sobi receipt and Q1 2028, and that research should be done by reading originals and validating information, especially for strong or new information, while weak or absent information should be verified and cash should be used for reverification.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 20, 2026, at 10:16:05 UTC. The fund is tracking several companies, including IONS, MIRM, GIS, and EAT, as well as CAG. A news scan found the following SEC filings: IONS on September 4, 2026, MIRM on September 8, 2026, GIS on July 1, 2026, and EAT on September 17, 2026. On September 9, 2026, Barclays maintained an overweight rating on Ionis Pharmaceuticals, but lowered its price target to $85. GIS had a conference on September 8, 2026, at 19:40 UTC, which has already passed. The company will release its earnings on September 23, 2026, at 13:00 UTC, with a Q&A session, but the exact time of the first release is unknown. The fund's strategy for GIS is to record and validate if the company's organic cash is strong, and to reverify if it is weak or absent. The baseline for GIS's FY27 EPS is $3.00-3.20, with organic growth of -1.5% to +0.5%, and savings of $750 million. The fund also tracks EAT, which had an investor day on September 17, 2026, and will have an earnings call on October 28, 2026, with the exact time unknown. The fund's strategy for EAT is to record and validate if the company's organic cash is strong, and to reverify if it is weak or absent. The fund does not have any automatic trades set up, and all dates are for review purposes only, not for first news. The fund's status is currently set to research only, with no orders, as of September 20, 2026, at 10:16:07 UTC.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 20, 2026, at 09:31:03 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager looked at news releases from SAIL, KFY, and LOVE, which were published on September 9, 2026, September 9, 2026, and September 15, 2026, respectively. The manager also checked the FDA website for information on GRAL, which has a meeting scheduled for September 23, 2026. The manager notes that SEC filings may not be up to date with news and will review results on the following schedule: September 9 at 12:30 for new morning results, September 10 at 12:30 for LOVE, and September 24 at 12:30 for SFIX after the September 23 AMC. The manager also notes that the GRAL panel on September 23 is not an approval. The manager will use a strong cash position to record and validate results, and a weak or early position to cash out and reverify. No automatic orders were placed.

The Catalyst research fund has a size of 0 as of 2026-09-20T07:01:03.676965+00:00 UTC. Recent news includes: TLX on Thu, 17 Sep 2026, with a link to https://telixpharma.com/news-views/lets-go-lets-get-them/, AVO on Tue, 08 Sep 2026, with a link to https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial, ABM on Tue, 08 Sep 2026, with a link to https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results, and ROIV on Tue, 08 Sep 2026, with a link to https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. Financial reports include UNFI's 10-K on 2026-09-14, DRI's 10-K on 2026-07-24, PPIH's 10-Q on 2026-09-09, MRK's 10-Q on 2026-08-07, and WLTH's 10-Q on 2026-09-14. Other updates include EPM on Tue, 15 Sep 2026, with a link to https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-reports-fiscal-fourth-quarter-and-full-0, and IPHA's 6-K on 2026-09-17. HTTP requests returned the following hashes: KGF with hash 9ef4336aeb9528cc, ASKUL with hash e6f0d85c03a37ce6, IPHAnews with hash ef3293fd5ff26cb3, and SOBI with hash 7569409d160b2a08. The research notes end with the instruction to preserve monitors 165, 168, 167, 137, and 22, and to take no orders.

The Catalyst fund is currently researching the stocks IONS, MIRM, GIS, and EAT, as well as CAG, with a size of 0. The fund's status was updated on September 20, 2026, at 06:01:04 UTC. The fund manager has been reviewing SEC filings for these stocks, including IONS on September 4, MIRM on September 8, GIS on July 1, and EAT on September 17. A news scan found the headline that Barclays maintains an overweight rating on Ionis Pharmaceuticals, but lowers its price target to $85. The GIS company had a conference on September 8, and its earnings will be released on September 23. The fund manager will review the earnings on September 23 at 13:00 UTC. The baseline for GIS is an EPS of $3.00-3.20, with organic growth of -1.5 to +0.5%, and savings of $750 million. The EAT company had an investor day on September 17, and its earnings call will be on October 28. The fund manager will review the earnings on October 28 at 16:30 UTC. The fund is set to research only, with no orders, as of September 20, 2026, at 06:01:07 UTC.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 20, 2026, at 05:31:03 UTC. The fund reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. It also reviewed the 8-K filing for SFIX on July 28, 2026. Additionally, the fund looked at RSS feeds from SAIL on September 9, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The fund also checked the FDA website for information on GRAL, which has a meeting scheduled for September 23, 2026. The fund will review new morning results on September 9 at 12:30, LOVE results on September 10 at 12:30, and SFIX results on September 24 at 12:30, after the September 23 AMC. The GRAL panel meeting on September 23 is not for approval. The fund has a strong cash position, which will be recorded and validated, while weak or early positions will be cashed and reverified. No automatic orders were placed.

A fund manager's notes were compiled on 2026-09-20T03:16:10.593834+00:00. The fund is called Catalyst Research, and it has a size of 0. The notes include compact receipts and originate from the PRE91108 archive. The notes are divided into 11 panels, each with a unique identifier, or sha, which is a type of digital fingerprint. The panels contain previews of various documents and news articles, including SEC filings for HITI and BFRI, and a report from Dave & Buster's. One panel mentions a review of TSM on September 10 at 06:00 UTC, and another mentions a conference call for CAN on September 8 at 12:30. The notes also mention EGTX, a company with 48 MFN counts, and a hash of 85e339a790c3. A news scan found the headline 'Dave & Buster's Reports Second Quarter 2026' on September 14, 2026. The notes also reference an ITC, which stands for International Trade Commission, and a suspension that was lifted on September 1, 2026. The originals of these documents should be read before taking any action.

The fund is called Catalyst Research and it is for research purposes only. The fund size was checked at 0 UTC on 2026-09-20T03:01:04.075432+00:00. There are several news updates: TLX on Thursday, 17 Sep 2026, from https://telixpharma.com/news-views/lets-go-lets-get-them/, AVO on Tuesday, 08 Sep 2026, from https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial, ABM on Tuesday, 08 Sep 2026, from https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results, and ROIV on Tuesday, 08 Sep 2026, from https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. There are also financial reports: UNFI on 2026-09-14, DRI on 2026-07-24, PPIH on 2026-09-09, MRK on 2026-08-07, and WLTH on 2026-09-14. Additionally, EPM reported on Tuesday, 15 Sep 2026, from https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-reports-fiscal-fourth-quarter-and-full-0, and IPHA filed a 6-K on 2026-09-17. The HTTP status code 200 was received for KGF, ASKUL, IPHAnews, and SOBI, with corresponding hashes. The research notes that IPHA is important on September 17, and there is a condition related to Sobi receipt and Q1-2028. The monitors for 165, 168, 167, 137, and 22 should be preserved. The sources and dates are recorded in the job script and journal. No orders were placed.

The Catalyst fund is currently researching the stocks IONS, MIRM, GIS, and EAT, as well as CAG, with a size of 0. The fund's status was updated on September 20, 2026, at 01:46:05 UTC. The fund manager has been reviewing SEC filings for these stocks, including IONS on September 4, MIRM on September 8, GIS on July 1, and EAT on September 17. A news scan found the headline that Barclays maintains an overweight rating on Ionis Pharmaceuticals and lowers its price target to $85 on September 9. The GIS company had a conference on September 8, and its earnings report is scheduled for September 23. The fund manager will review the earnings report and verify the company's organic cash and guidance. If the guidance is stronger, the manager will record and validate it, but if it is weaker or absent, the manager will reverify the cash. The fund manager has also been tracking EAT's investor day on September 17 and its upcoming earnings call on October 28. The manager will review the earnings call and verify the first news release. The fund's baseline for GIS is an EPS of $3.00-3.20 and organic growth of -1.5% to +0.5%. The fund manager has frozen the paper window from September 16 to September 21 and will not retune past tests. The fund's current status is research only, with no orders, as of September 20, 2026, at 01:46:08 UTC.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 20, 2026, at 01:16:03 UTC. The fund reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. It also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the fund looked at news from SAIL, KFY, and LOVE, which were released on September 9, 2026, and September 15, 2026. The fund also checked the FDA website for information on GRAL, which had a meeting scheduled for September 23, 2026. The fund noted that SEC filings may lag behind news. It reviewed results on September 9 and 10, and will review results from SFIX on September 24, after the market closes on September 23. The fund noted that the GRAL meeting on September 23 was not for approval. The fund has a strong cash position, which it will record and validate, but it will cash out and reverify weak or early positions. The fund will not place any automatic orders.

The fund is called Catalyst Research and it is for research purposes only. The fund size is 0 and the time is 2026-09-19T23:01:05.191615+00:00 UTC. There are several companies with updates: TLX on Thursday, 17 Sep 2026, has a news article at https://telixpharma.com/news-views/lets-go-lets-get-them/, AVO on Tuesday, 08 Sep 2026, has a news release at https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial, ABM on Tuesday, 08 Sep 2026, has a news release at https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results, and ROIV on Tuesday, 08 Sep 2026, has a news release at https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. Additionally, there are financial reports from UNFI on 2026-09-14, DRI on 2026-07-24, PPIH on 2026-09-09, MRK on 2026-08-07, and WLTH on 2026-09-14. EPM also had a news release on Tuesday, 15 Sep 2026, at https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-reports-fiscal-fourth-quarter-and-full-0. Furthermore, IPHA had a 6-K report on 2026-09-17. The HTTP requests for KGF, ASKUL, IPHAnews, and SOBI were successful with hashes 9ef4336aeb9528cc, e6f0d85c03a37ce6, ef3293fd5ff26cb3, and 7569409d160b2a08 respectively. The research notes that IPHA has an update on September 17 and Sobi has a receipt conditional on Q1-2028. The monitors 165, 168, 167, 137, and 22 should be preserved. The sources and dates are in the job script and journal. There are no orders.